DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Infection Control and Biosafety Products Market 2017-2021" report to their offering.
The global infection control and biosafety products market to grow at a CAGR of 4.21% during the period 2017-2021.
This report, Global Infection Control and Biosafety Products Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one of the major drivers for this market is outbreak of life-threatening diseases. A disease outbreak is the occurrence of a disease in excess of what can normally be expected in a given community, region, or season. In recent years, the outbreak of various diseases has affected several countries across the world. Diseases caused by bacteria like E. coli have been rampant in recent years. Lack of proper hygiene and sanitation is a major reason for the spread of diseases. A low-level of hygiene during hospital stay and patient care also creates a breeding ground for various microorganisms, such as viruses, bacteria, and spores that can lead to the spread of diseases.
- Reckitt Benckiser
- BODE Chemie
Thermo Fisher Scientific
Other prominent vendors:
- ABC Compounding
- American Biotech Labs
- Bio-Cide International
- CareFusion (BD)
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by products
Part 07: Geographical segmentation
Part 08: Market segmentation by end-user
Part 09: Decision framework
Part 10: Drivers and challenges
Part 11: Market trends
Part 12: Vendor landscape
Part 13: Key vendor analysis
For more information about this report visit http://www.researchandmarkets.com/research/tcvjp8/global_infection